サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1393908

欧州の心臓AIモニタリングおよび診断市場の分析・予測：2023-2032年

Europe Cardiac AI Monitoring and Diagnostics Market - Analysis and Forecast, 2023-2032
出版日: | 発行: BIS Research | ページ情報: 英文 133 Pages | 納期: 1～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
欧州の心臓AIモニタリングおよび診断市場の分析・予測：2023-2032年
出版日: 2023年12月08日
発行: BIS Research
ページ情報: 英文 133 Pages
納期: 1～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の心臓AIモニタリングおよび診断の市場規模は、2022年の2億7,560万米ドルから、予測期間中は28.09%のCAGRで推移し、2032年には31億9,990万米ドルの規模に成長すると予測されています。

世界の心血管疾患の有病率の高さ、AI導入に向けた政府のイニシアチブの拡大、心臓AI分野の研究の拡大、心臓疾患診断用のAI医療機器の承認の増加、心臓AI診断分野の技術の進歩などの要因が同市場の成長を後押しする主な要因となっています。

当レポートでは、欧州の心臓AIモニタリングおよび診断の市場を調査し、市場概要、市場成長への各種影響因子の分析、特許動向、法規制環境、ケーススタディ、市場規模の推移・予測、各種区分・主要国別の詳細分析、競合情勢、主要企業の分析などをまとめています。

主要市場統計
予測期間 2023-2032年
2023年評価 3億4,470万米ドル
2032年予測 31億9,990万米ドル
CAGR 28.09%

市場の分類

セグメンテーション1：製品別

  • ソフトウェア
  • ハードウェア

セグメンテーション2：タイプ別

  • 心臓疾患診断
    • 画像診断
    • 心電図ベース
    • その他
  • 心臓モニタリング

セグメンテーション3：用途別

  • 虚血性心疾患/CAD
  • 心臓不整脈
  • 虚血性脳卒中
  • その他

セグメンテーション4：エンドユーザー別

  • 病院
  • 診断センター
  • その他

セグメンテーション5：国別

  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他

目次

第1章 市場

  • 市場の見通し

第2章 業界の展望

  • 主要な動向
  • 機会の評価
  • 規制の枠組み
  • 特許分析
  • ビジネスモデル
  • ケーススタディ
    • ケーススタディ1：Ultromics Limited
    • ケーススタディ2：CorVista Health, Inc.
  • 進行中の臨床試験
  • 資金調達シナリオ
  • エンドユーザーの認識
  • 新規参入者の参入の障壁

第3章 地域

  • 欧州の心臓AIモニタリングおよび診断市場
    • 主な調査結果と機会の評価
    • デジタルの導入
    • 市場力学
    • 市場規模・予測

第4章 市場：競合ベンチマーキング・企業プロファイル

  • アクティブ企業のエコシステム
  • 主要な戦略・展開
  • 企業プロファイル
    • Koninklijke Philips N.V.
    • Medicalgorithmics S.A.
    • Siemens Healthineers AG
    • Ultromics Limited.
図表

List of Figures

  • Figure 1: AI in Cardiac Monitoring and Diagnosis
  • Figure 2: Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 3: Cardiac AI Monitoring and Diagnostics Market, Market Dynamics
  • Figure 4: Key Trends in the Cardiac AI Monitoring and Diagnostics Market
  • Figure 5: Entry Barriers for New Entrants
  • Figure 6: Cardiac AI Monitoring and Diagnostics Market Share (by Product), 2022 and 2032
  • Figure 7: Cardiac AI Monitoring and Diagnostics Market Share (by Type), 2022 and 2032
  • Figure 8: Cardiac AI Monitoring and Diagnostics Market Share (by Application), 2022 and 2032
  • Figure 9: Cardiac AI Monitoring and Diagnostics Market Share (by End Users), 2022 and 2032
  • Figure 10: Cardiac AI Monitoring and Diagnostics Market (by Region), $Million, 2022
  • Figure 11: Key Developments and Strategies Analysis, January 2020-June 2023
  • Figure 12: Cardiac AI Monitoring and Diagnostics Market: Research Methodology
  • Figure 13: Primary Research Methodology
  • Figure 14: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 15: Top-Down Approach (Segment-Wise Analysis)
  • Figure 16: Overview of the Role of AI in Cardiology
  • Figure 17: Cardiac AI Monitoring and Diagnostics Market, Size and Growth Potential, $Million, 2022-2032
  • Figure 18: Cardiac AI Monitoring and Diagnostics Market, Key Trends
  • Figure 19: Potential of AI for Processing Patient's Own Data
  • Figure 20: Advantages of AI-Enabled Wearable Sensors for Cardiac Monitoring
  • Figure 21: Cardiac AI Monitoring and Diagnostics Market, Key Trends, Opportunity Assessment, 2023-2032
  • Figure 22: Regulatory Process for Medical Devices in the U.S.
  • Figure 23: Cardiac AI Monitoring and Diagnostics Market, Patent Analysis (by Country), January 2018-June 2023
  • Figure 24: Cardiac AI Monitoring and Diagnostics Market, Patent Analysis (by Year), January 2018-June 2023
  • Figure 25: Different Types of Business Models in the AI in Healthcare Scenario
  • Figure 26: Subscription-Based Model the Market is Shifting Towards
  • Figure 27: Partners of Ultromics Limited
  • Figure 28: Ultromics Limited:Awards and Recognitions
  • Figure 29: The CorVista System
  • Figure 30: Cardiac AI Monitoring and Diagnostics Market, Quarterly Analysis of Funding Scenario, January 2020-June 2023
  • Figure 31: Cardiac AI Monitoring and Diagnostics Market, End User Perceptions
  • Figure 32: Entry Barriers for New Entrants
  • Figure 33: Recommendations to Tackle the Entry Barriers
  • Figure 34: Cardiac AI Monitoring and Diagnostics Market Share (by Region), 2022-2032
  • Figure 35: Europe Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by Country), $Million, 2023-2032
  • Figure 36: Digital Competence Framework for Citizens Developed by the European Commission
  • Figure 37: Europe Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 38: Europe Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 39: Europe Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 40: Europe Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 41: Europe Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 42: Europe Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 43: Europe Cardiac AI Monitoring and Diagnostics Market (by Country), % Share, 2022 and 2032
  • Figure 44: Germany Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 45: Germany Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 46: Germany Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 47: Germany Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 48: Germany Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 49: Germany Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 50: U.K. Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 51: U.K. Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 52: U.K. Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 53: U.K. Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 54: U.K. Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 55: U.K. Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 56: France Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 57: France Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 58: France Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 59: France Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 60: France Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 61: France Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 62: Italy Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 63: Italy Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 64: Italy Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 65: Italy Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 66: Italy Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 67: Italy Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 68: Spain Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 69: Spain Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 70: Spain Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 71: Spain Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 72: Spain Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 73: Spain Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 74: Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 75: Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 76: Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 77: Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 78: Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 79: Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 80: Share of Key Developments and Strategies, January 2019-June 2023
  • Figure 81: Regulatory and Legal Activities (by Company), January 2019-June 2023
  • Figure 82: Partnerships, Alliances, and Business Expansions (by Company), January 2019-June 2023
  • Figure 83: Funding Activities (by Company), January 2019-June 2023
  • Figure 84: New Offerings (by Company), January 2019-June 2023
  • Figure 85: Mergers and Acquisitions (by Company), January 2019-June 2023
  • Figure 86: Koninklijke Philips N.V.: Overall Product Portfolio
  • Figure 87: Koninklijke Philips N.V.: Overall Financials, $Million, 2020-2022
  • Figure 88: Koninklijke Philips N.V.: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 89: Koninklijke Philips N.V.: Revenue (by Region), $Million, 2020-2022
  • Figure 90: Koninklijke Philips N.V.: R&D Expenditure, $Million, 2022-2022
  • Figure 91: Medicalgorithmics S.A.: Overall Product Portfolio
  • Figure 92: Siemens Healthineers AG: Overall Product Portfolio
  • Figure 93: Siemens Healthineers AG: Overall Financials, $Million, 2020-2022
  • Figure 94: Siemens Healthineers AG: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 95: Siemens Healthineers AG: Net Revenue (by Region), $Million, 2020-2022
  • Figure 96: Siemens Healthineers AG: R&D Expenditure, $Million, 2020-2022
  • Figure 97: Ultromics Limited.: Overall Product Portfolio

List of Tables

  • Table 1: Regulatory Framework
  • Table 2: Key Questions Answered in the Report
  • Table 3: Startups Entering the Market
  • Table 4: Regulatory Framework of Different Countries
  • Table 5: Cardiac AI Monitoring and Diagnostics Market, Awaited Technological Developments
  • Table 6: CorVista Health Inc. Publications
  • Table 7: Cardiac AI Monitoring and Diagnostics Market, Ongoing Clinical Trials
  • Table 8: Investments and Fundings in Cardiac AI Monitoring and Diagnostics Market
  • Table 9: Europe Cardiac AI Monitoring and Diagnostics Market, Impact Analysis
  • Table 10: Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
目次
Product Code: BHD1600SS

“The Europe Cardiac AI Monitoring and Diagnostics Market Expected to Reach $3,199.9 Million by 2032.”

Introduction to Europe Cardiac AI Monitoring and Diagnostics Market

The Europe cardiac AI monitoring and diagnostics market was valued at $275.6 million in 2022 and is anticipated to reach $3,199.9 million by 2032, witnessing a CAGR of 28.09% during the forecast period 2023-2032. The high prevalence of cardiovascular diseases worldwide, rising government initiatives for AI adoption, expanding research in the field of AI for cardiology, rising regulatory approvals of cardiac diagnostics AI medical devices, and technological advancements in the field of cardiac AI diagnostics are the main factors propelling the growth of the europe market for cardiac AI monitoring and diagnostics.

KEY MARKET STATISTICS
Forecast Period2023 - 2032
2023 Evaluation$344.7 Million
2032 Forecast$3,199.9 Million
CAGR28.09%

Market Introduction

The market for cardiac AI monitoring and diagnostics in Europe has grown and advanced significantly in recent years. Cardiologists are using artificial intelligence (AI) technology more and more to improve diagnoses and monitoring for a range of heart diseases.

Vast volumes of patient data, like as electrocardiograms (ECGs), imaging scans, and patient histories, can be analyzed by AI-powered cardiac monitoring systems in order to find and identify anomalies or possible cardiac diseases. These technologies can enhance patient outcomes, offer prompt and accurate diagnoses, and support healthcare personnel in making decisions by utilizing AI algorithms and machine learning.

There are many benefits of using AI in cardiac monitoring and diagnostics. It makes patient data analysis more thorough and efficient, which helps identify cardiac problems early on, which is essential for prompt intervention and treatment. In addition, AI algorithms can help with risk management and stratification by locating high-risk patients and enhancing treatment regimens.

Furthermore, telehealth applications in the field of cardiology and remote monitoring are made possible by AI technology. AI-enabled wearables and sensors can send real-time data to healthcare providers while continuously monitoring a patient's heart parameters. This enhances patient access to care and lowers healthcare costs by enabling remote management of chronic illnesses, early detection of arrhythmias or cardiac events, and remote monitoring of high-risk patients.

Technology businesses, healthcare providers, and research organizations are investing heavily and collaborating in the European cardiac AI monitoring and diagnostics industry. A favorable regulatory environment, rising cardiovascular disease prevalence, and growing demand for sophisticated cardiac monitoring and diagnostics are propelling the market expansion in the area.

But there are still issues to be resolved, like worries about data security and privacy, a lack of compatibility between various AI systems, and the requirement for thorough assessment and legal clearance of AI algorithms. Standardized methods and recommendations for the application of AI in cardiac monitoring and diagnostics are being developed in order to guarantee patient safety and encourage broad adoption among European nations.

Market Segmentation:

Segmentation 1: by Product

  • Software
  • Hardware

Segmentation 2: by Type

  • Cardiac Diagnostics
    • Imaging
    • ECG-Based
    • Others
  • Cardiac Monitoring

Segmentation 3: by Application

  • Ischemic Heart Disease/CAD
  • Cardiac Arrhythmias
  • Ischemic Stroke
  • Others

Segmentation 4: by End User

  • Hospitals
  • Diagnostic Centers
  • Other End Users

Segmentation 5: by Country

  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest-of-Europe

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The europe cardiac AI monitoring and diagnostics market has been extensively segmented based on various categories, such as products, types, applications, end users, and regions. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.

Some of the prominent names in this market are:

  • Koninklijke Philips N.V.
  • Medicalgorithmics S.A.
  • Siemens Healthineers AG
  • Ultromics Limited.

Table of Contents

1 Market

  • 1.1 Market Outlook
    • 1.1.1 Product Definition
    • 1.1.2 Inclusion Criteria
    • 1.1.3 Exclusion Criteria
    • 1.1.4 Overview
      • 1.1.4.1 Market Size and Growth Potential

2 Industry Outlook

  • 2.1 Key Trends
    • 2.1.1 Rising Number of Startups in the Market
    • 2.1.2 Increased Awareness Regarding Preventative Measures and Personalized Treatment
    • 2.1.3 Growing Demand for Wearable Sensors for Cardiac Monitoring Leading to Increased Adoption of AI-Enabled Solutions for Home-Based Care
  • 2.2 Opportunity Assessment
  • 2.3 Regulatory Framework
    • 2.3.1 Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
    • 2.3.2 Regulatory Framework in the U.S.
    • 2.3.3 Regulatory Framework in Europe
    • 2.3.4 Regulatory Framework in Japan
    • 2.3.5 Regulatory Framework in China
    • 2.3.6 Regulatory Framework in the Other Countries
  • 2.4 Patent Analysis
    • 2.4.1 Awaited Technological Developments
      • 2.4.1.1 Patent Analysis (by Country)
      • 2.4.1.2 Patent Analysis (by Year)
  • 2.5 Business Models
  • 2.6 Case Studies
    • 2.6.1 Case Study 1: Ultromics Limited
      • 2.6.1.1 The EchoGo System
        • 2.6.1.1.1 Developement
        • 2.6.1.1.2 Use Case and Reliability
      • 2.6.1.2 A Success Story
      • 2.6.1.3 Partners and Recognitions
    • 2.6.2 Case Study 2: CorVista Health, Inc.
      • 2.6.2.1 The CorVista System
      • 2.6.2.2 A Success Story
  • 2.7 Ongoing Clinical Trials
  • 2.8 Funding Scenario
  • 2.9 End User Perception
  • 2.1 Entry Barriers for New Entrants

3 Regions

  • 3.1 Europe Cardiac AI Monitoring and Diagnostics Market
    • 3.1.1 Key Findings and Opportunity Assessment
    • 3.1.2 Digital Adoption
    • 3.1.3 Market Dynamics
      • 3.1.3.1 Impact Analysis
    • 3.1.4 Market Sizing and Forecast
      • 3.1.4.1 Europe Cardiac AI Monitoring and Diagnostics Market (by Product)
      • 3.1.4.2 Europe Cardiac AI Monitoring and Diagnostics Market (by Type)
        • 3.1.4.2.1 Europe Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
      • 3.1.4.3 Europe Cardiac AI Monitoring and Diagnostics Market (by Application)
      • 3.1.4.4 Europe Cardiac AI Monitoring and Diagnostics Market (by End User)
      • 3.1.4.5 Europe Cardiac AI Monitoring and Diagnostics Market (by Country)
        • 3.1.4.5.1 Germany
          • 3.1.4.5.1.1 Market Dynamics
          • 3.1.4.5.1.2 Market Size and Forecast
          • 3.1.4.5.1.2.1 Germany Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 3.1.4.5.1.2.2 Germany Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 3.1.4.5.1.2.2.1 Germany Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 3.1.4.5.1.2.3 Germany Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 3.1.4.5.1.2.4 Germany Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 3.1.4.5.2 U.K.
          • 3.1.4.5.2.1 Market Dynamics
          • 3.1.4.5.2.2 Market Size and Forecast
          • 3.1.4.5.2.2.1 U.K. Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 3.1.4.5.2.2.2 U.K. Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 3.1.4.5.2.2.2.1 U.K. Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 3.1.4.5.2.2.3 U.K. Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 3.1.4.5.2.2.4 U.K. Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 3.1.4.5.3 France
          • 3.1.4.5.3.1 Market Dynamics
          • 3.1.4.5.3.2 Market Size and Forecast
          • 3.1.4.5.3.2.1 France Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 3.1.4.5.3.2.2 France Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 3.1.4.5.3.2.2.1 France Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 3.1.4.5.3.2.3 France Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 3.1.4.5.3.2.4 France Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 3.1.4.5.4 Italy
          • 3.1.4.5.4.1 Market Dynamics
          • 3.1.4.5.4.2 Market Size and Forecast
          • 3.1.4.5.4.2.1 Italy Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 3.1.4.5.4.2.2 Italy Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 3.1.4.5.4.2.2.1 Italy Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 3.1.4.5.4.2.3 Italy Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 3.1.4.5.4.2.4 Italy Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 3.1.4.5.5 Spain
          • 3.1.4.5.5.1 Market Dynamics
          • 3.1.4.5.5.2 Market Size and Forecast
          • 3.1.4.5.5.2.1 Spain Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 3.1.4.5.5.2.2 Spain Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 3.1.4.5.5.2.2.1 Spain Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 3.1.4.5.5.2.3 Spain Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 3.1.4.5.5.2.4 Spain Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 3.1.4.5.6 Rest-of-Europe
          • 3.1.4.5.6.1 Market Size and Forecast
          • 3.1.4.5.6.1.1 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 3.1.4.5.6.1.2 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 3.1.4.5.6.1.2.1 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 3.1.4.5.6.1.3 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 3.1.4.5.6.1.4 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by End User)

4 Markets - Competitive Benchmarking & Company Profiles

  • 4.1 Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
  • 4.2 Key Strategies and Developments
    • 4.2.1 Regulatory and Legal Activities
    • 4.2.2 Partnerships, Alliances, and Business Expansions
    • 4.2.3 Funding Activities
    • 4.2.4 New Offerings
    • 4.2.5 Mergers and Acquisitions
  • 4.3 Company Profiles
    • 4.3.1 Koninklijke Philips N.V.
      • 4.3.1.1 Company Overview
      • 4.3.1.2 Role of Koninklijke Philips N.V. in the Cardiac AI Monitoring and Diagnostics Market
      • 4.3.1.3 Financials
      • 4.3.1.4 Key Developments
      • 4.3.1.5 Analyst Perception
    • 4.3.2 Medicalgorithmics S.A.
      • 4.3.2.1 Company Overview
      • 4.3.2.2 Role of Medicalgorithmics S.A. in the Cardiac AI Monitoring and Diagnostics Market
      • 4.3.2.3 Key Developments
      • 4.3.2.4 Analyst Perception
    • 4.3.3 Siemens Healthineers AG
      • 4.3.3.1 Company Overview
      • 4.3.3.2 Role of Siemens Healthineers AG in the Cardiac AI Monitoring and Diagnostics Market
      • 4.3.3.3 Financials
      • 4.3.3.4 Analyst Perception
    • 4.3.4 Ultromics Limited.
      • 4.3.4.1 Company Overview
      • 4.3.4.2 Role of Ultromics Limited. in the Cardiac AI Monitoring and Diagnostics Market
      • 4.3.4.3 Key Developments
      • 4.3.4.4 Analyst Perception